Certara stock.
What is the support and resistance for Certara (CERT) stock price? CERT support price is $14.50 and resistance is $15.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT stock …
The estimated Net Worth of Richard M. Traynor is at least $8.32 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,497,341 and over the last 3 years he sold CERT stock worth over $5,825,760.Certara, Inc. (CERT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.01 per share a year ago.Nov 21, 2023 · Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ... 1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price.
Nov 24, 2023 · View Certara, Inc CERT investment & stock information. Get the latest Certara, Inc CERT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...Nov 28, 2023 · CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth. Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today ...
Certara Stock Performance NASDAQ CERT opened at $14.64 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.51 and a quick ratio of 3.51.
1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Avatar has made over 8 trades of the Certara stock since 2020, according to the Form 4 filled with the SEC. Most recently Avatar sold 29,954,521 units of CERT stock worth $449,317,815 on 8 December 2022.The estimated net worth of Robert Aspbury is at least $5.51 million as of June 14th, 2021. Dr. Aspbury owns 375,451 shares of Certara stock worth more than $5,511,621 as of November 28th. This net worth estimate does not reflect any other investments that Dr. Aspbury may own.... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...Here are three high-yield tech stocks worth considering right now. With its stock down around 10% over the past year and a dividend yielding 3.4% annually as of this writing, semiconductor giant ...13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.The estimated Net Worth of Leif E Pedersen is at least $6.21 Millón dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,354,541 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.The estimated Net Worth of Leif E Pedersen is at least $7.01 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $4,150,575 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.
The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.Third Quarter Highlights: Revenue was $85.6 million, PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023.Investors in Certara, Inc. CERT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2023 $12.50 Call had some of the highest implied ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...
When is Certara (NASDAQ:CERT) reporting earnings? A. Certara ( CERT) is scheduled to report earnings on February 28, 2024. The last reported earnings were for reported on November 8, 2023 for Q3. Q.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ...Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services. How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.In other Certara news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $14.60, for a total transaction of $747,870.40. Following the transaction, the insider now directly owns 128,883 shares in the company, valued at $1,881,691.80.Here are three high-yield tech stocks worth considering right now. With its stock down around 10% over the past year and a dividend yielding 3.4% annually as of this writing, semiconductor giant ...Reiterates Full Year 2023 Financial GuidancePRINCETON, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results ...Dec 1, 2023 · Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?
Investors in Certara, Inc. CERT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2023 $12.50 Call had some of the highest implied ...
Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...
Current stock price of Certara, Inc. (CERT) online. Stock quotes and charts for Certara, Inc. (CERT) on the website of Just2Trade broker.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?The estimated Net Worth of Leif E Pedersen is at least $7.01 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $4,150,575 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools …Certara Inc’s stock is NA in 2023, NA in the previous five trading days and up 17.38% in the past year. Currently, Certara Inc’s price-earnings ratio is 112.4. Certara Inc’s trailing 12-month revenue is $352.1 million with a 5.4% net profit margin. Year-over-year quarterly sales growth most recently was 9.3%.Certara, Inc. (NASDAQ:CERT), is not the largest company out there, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US ...Certara's software platform Simcyp group awarded two new grants from US FDA Certara downgraded at Jefferies on growth headwinds Certara Non-GAAP EPS of $0.12 misses by $0.01, revenue of $90.45M ...
PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the …Instagram:https://instagram. asus rog flow x13 2023rev translation documentswhy are gas prices going downelectric tundra Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development. best rated jewelry insurance companiesotcmkts bzamf Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ... Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent … how much is an ingot of gold 7 Nov 2022 ... png. Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase. Arsenal will acquire ...The estimated Net Worth of Leif E Pedersen is at least $7.01 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $4,150,575 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.